Aequus Pharmaceuticals Stock Today
| AQSZF Stock | USD 0.01 0.0005 7.04% |
Performance0 of 100
| Odds Of DistressLess than 10
|
Aequus Pharmaceuticals is trading at 0.0066 as of the 27th of November 2024. This is a 7.04 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.0066. Aequus Pharmaceuticals has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Aequus Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of October 2024 and ending today, the 27th of November 2024. Click here to learn more.
Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, develops and commercializes drugs in Canada. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada. Aequus Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. The company has 132.63 M outstanding shares. More on Aequus Pharmaceuticals
Moving together with Aequus OTC Stock
| 0.64 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.71 | PPERF | Bank Mandiri Persero | PairCorr |
| 0.77 | BKRKF | PT Bank Rakyat | PairCorr |
| 0.69 | TLK | Telkom Indonesia Tbk | PairCorr |
Moving against Aequus OTC Stock
| 0.9 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.89 | PTAIF | PT Astra International | PairCorr |
| 0.88 | SSNLF | Samsung Electronics | PairCorr |
| 0.88 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.85 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.84 | INTC | Intel Fiscal Year End 23rd of January 2025 | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Aequus OTC Stock Highlights
| Chairman, CEO and Pres | Douglas Janzen |
| Business Concentration | Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Aequus Pharmaceuticals [AQSZF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.12 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aequus Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Aequus Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Aequus Pharmaceuticals classifies itself under Pharmaceuticals sector and is part of Health Care industry. The entity has 132.63 M outstanding shares.
Aequus Pharmaceuticals has accumulated about 1.39 M in cash with (1.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Aequus Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationAequus Pharmaceuticals holds a total of 132.63 Million outstanding shares. Aequus Pharmaceuticals shows 14.96 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Aequus Ownership Details
Aequus Pharmaceuticals Risk Profiles
| Mean Deviation | 2.82 | |||
| Standard Deviation | 6.87 | |||
| Variance | 47.14 | |||
| Risk Adjusted Performance | (0.09) |
Aequus Stock Against Markets
Picking the right benchmark for Aequus Pharmaceuticals otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Aequus Pharmaceuticals otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Aequus Pharmaceuticals is critical whether you are bullish or bearish towards Aequus Pharmaceuticals at a given time. Please also check how Aequus Pharmaceuticals' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Aequus Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
Other Information on Investing in Aequus OTC Stock
Aequus Pharmaceuticals financial ratios help investors to determine whether Aequus OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aequus with respect to the benefits of owning Aequus Pharmaceuticals security.